Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 21, 2016

View Archived Issues

Drug resistance specter is fact of life for antibiotics

Digging for answers
(in the ground and IP)

Are we at risk of living in a post-antibiotic world?

CMS suspends lab fee do-over, adds hospital labs to fee calculation

IPRs emerge from SC challenge alive, robust

Other news to note

Financings

Product briefs

Keeping you up to date on recent developments with Cardiology

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.